Term ends Jan 15, 2034 · High confidence
20-year base term ends Sep 26, 2028
Held by Alexion Pharmaceuticals, Inc.
Filed Sep 26, 2008 as application 12/239,651 · Granted Apr 10, 2012
Base term plus 622 days of patent term adjustment (USPTO delay)
Today
2008
2034
Clock starts
Sep 26, 2008
Sep 26, 2008
Term ends
Jan 15, 2034
Jan 15, 2034
Granted
Apr 10, 2012
Apr 10, 2012
base term
patent term adjustment
fee events
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
622
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
14
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 622 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Sep 26, 2008, when this application, 12/239,651, was filed | Sep 26, 2028 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +622 days, USPTO patent term adjustment record | Jun 10, 2030 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | +1315 days, USPTO 35 U.S.C. 156 certificate | added to Jun 10, 2030: Jan 15, 2034 | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jan 15, 2034 | High confidence |
This family
| US 8,153,590 | this patent Jan 2034 | Jan 2034 |
| US 8,268,783 | In force Feb 2029 | Feb 2029 |
| US 8,455,441 | In force no later than Sep 2028 | no later than Sep 2028 |
| US 9,109,046 | In force Jan 2029 | Jan 2029 |
| US 9,062,298 | In force no later than Sep 2028 | no later than Sep 2028 |
| US 8,889,129 | In force no later than Sep 2028 | no later than Sep 2028 |
| US 9,388,401 | In force Sep 2028 | Sep 2028 |
| US 9,587,233 | In force Sep 2028 | Sep 2028 |
8 of 14 applications in this family shown, earliest filings first. Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Dec 16, 2008 Reel 21989, frame 989 | Lu, Genmin; Phillips, David R. | Portola Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Apr 14, 2009 Reel 22546, frame 431 | Lu, Genmin; Phillips, David R.; Andre, Patrick; Sinha, Uma | Portola Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Mar 18, 2019 Reel 48633, frame 673 | Portola Pharmaceuticals, Inc. | HCR Collateral Management, LLC | Security Interest |
| Jul 2, 2020 Reel 53120, frame 925 | HCR Collateral Management, LLC | Portola Pharmaceuticals, Inc. | Release of Security Interest |
| Dec 17, 2020 Reel 54795, frame 162 | Portola Pharmaceuticals, Inc. | Portola Pharmaceuticals, LLC | Change of Name |
| Dec 17, 2020 Reel 54795, frame 630 | Portola Pharmaceuticals, LLC | Alexion Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Jan 5, 2021 Reel 54899, frame 357 | Portola Pharmaceuticals, Inc. | Portola Pharmaceuticals, LLC | Corrective Assignment to Correct the State of the Assignee Previously Recorded on Reel 054795 Frame 0162. Assignor(S) Hereby Confirms the Change of Name. |
| Feb 17, 2021 Reel 56014, frame 1 | Alexion Pharma International Operations Unlimited Company | Alexion Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Feb 17, 2021 Reel 56392, frame 716 | Alexion Pharmaceuticals, Inc. | Alexion Pharma International Operations Unlimited Company | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Jan 2034
Term ends Jan 15, 2034. No further fees fall due before then
Note
The 622 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
79
later US patents cite this one
That is top 10% of utility patents granted in 2012 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.